% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

  • noonangf1225 noonangf1225 Oct 14, 2013 3:58 PM Flag

    Investor Relations

    I called and spoke with Brendt Larson:

    a) Asked how many shares PM has. I think he said they were issued 35 million, though not sure and I'm not going to look it up.
    b) asked whether there might be credibility that they were shorting. He would not comment save to say that they are free to management investment assets however they do not seem to have gain by seeing the share price go South in the manner and duration it has.
    c) I asked re Partner announcement for Europe. He stated: '4th quarter is target'. (more specific than 'soon')
    d.) I mentioned that I was of the impression that NAVB stated a while ago that it wad flush with cash and cash-availability and also did not need to secure more cash through further dilution. He responded something like: 'we had varied access to cash...and that it need not be dilutive'. (Obviously they have chosen access to cash in both dilutive and non-dilutive manners).
    e.) I asked whether there was fear of a buyout at such a protracted low price. He steered fully/strongly away from that, stating that NAVB share price was in the hands of the market and buyer and sellers.
    g) I asked why there was so little/nominal insider buying. He stated that almost half the year NAVB employees are barred from purchases. (Obviously he simply chose not to answer why they didn't choose to buy the other half a year).

    That's it. If it helps, fine. If not, or you see it as 'rehash', then move on to next message....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.8369-0.0032(-0.38%)May 27 4:02 PMEDT